|  Register

Journal of Medical Economics

2019 Impact Factor
1.958

open access unlock icon An open access journal

Serving the international pharmacoeconomics and healthcare-research community, it publishes economic assessments of novel therapeutic and device interventions, along-side studies that measure therapeutic or preventative outcomes, and policy issues.
Advanced search
New content alerts RSS
Citation search

Citation search

Current issue Browse list of issues Explore
About this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Editing Services Awareness Chinese-speaking
Banner ad for Taylor & Francis journal suggester
Format-free submission

Journal news

Looking to publish open access? Read the Instructions for Authors and submit your paper today.

Latest 旺财体育

See all volumes and issues
Volume 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs

Journal of Medical Economics, Volume 23, Issue 11 (2020)

Special Section: Pricing Methods in Outcome-Based Contracting: The Six Delta Platform : Methods and Modeling
editorial
The six Delta platform for outcome-based contracting for pharmaceuticals
Nimer S. Alkhatib & Ivo Abraham
Pages: 1209-1214
Published online: 29 Sep 2020
First Page Preview | Full Text | References | PDF (790 KB) | Permissions聽

  • 461Views
  • 0CrossRef citations
  • Altmetric
旺财体育
Pricing methods in outcome-based contracting: 未1: cost effectiveness analysis and cost-utility analysis-based pricing
Nimer S. Alkhatib , Kenneth Ramos , Brian Erstad , Marion Slack , Ali McBride , Sandipan Bhattacharjee & Ivo Abraham
Pages: 1215-1222
Published online: 08 Sep 2020
Abstract | Full Text | References | PDF (1284 KB) | Supplemental | Permissions聽

  • 324Views
  • 7CrossRef citations
  • Altmetric
旺财体育
Pricing methods in outcome-based contracting: 未2: willingness-to-pay-based pricing
Nimer S. Alkhatib , Kenneth Ramos , Brian Erstad , Marion Slack , Ali McBride , Sandipan Bhattacharjee & Ivo Abraham
Pages: 1223-1229
Published online: 08 Sep 2020
Abstract | Full Text | References | PDF (1275 KB) | Supplemental | Permissions聽

  • 180Views
  • 6CrossRef citations
  • Altmetric
旺财体育
Pricing methods in outcome-based contracting: 未3: reference-based pricing
Nimer S. Alkhatib , Brian Erstad , Kenneth Ramos , Ali McBride , Sandipan Bhattacharjee , Marion Slack & Ivo Abraham
Pages: 1230-1236
Published online: 08 Sep 2020
Abstract | Full Text | References | PDF (983 KB) | Supplemental | Permissions聽

  • 165Views
  • 6CrossRef citations
  • Altmetric
旺财体育
Pricing methods in outcome-based contracting: 未4: safety-based pricing
Nimer S. Alkhatib , Sandipan Bhattacharjee , Ali McBride , Kenneth Ramos , Marion Slack , Brian Erstad & Ivo Abraham
Pages: 1237-1245
Published online: 08 Sep 2020
Abstract | Full Text | References | PDF (1153 KB) | Supplemental | Permissions聽

  • 154Views
  • 4CrossRef citations
  • Altmetric
旺财体育
Pricing methods in outcome-based contracting: 未5: risk of efficacy failure-based pricing
Nimer S. Alkhatib , Ali McBride , Sandipan Bhattacharjee , Kenneth Ramos , Brian Erstad , Marion Slack , Dean Billheimer & Ivo Abraham
Pages: 1246-1255
Published online: 08 Sep 2020
Abstract | Full Text | References | PDF (1909 KB) | Supplemental | Permissions聽

  • 176Views
  • 4CrossRef citations
  • Altmetric
旺财体育
Pricing methods in outcome-based contracting: 未6: adherence-based pricing
Nimer S. Alkhatib , Marion Slack , Sandipan Bhattacharjee , Brian Erstad , Kenneth Ramos , Ali McBride & Ivo Abraham
Pages: 1256-1265
Published online: 10 Sep 2020
Abstract | Full Text | References | PDF (1397 KB) | Supplemental | Permissions聽

  • 158Views
  • 2CrossRef citations
  • Altmetric
旺财体育
Pricing methods in outcome-based contracting: integration analysis of the six dimensions (6 未s)
Nimer S. Alkhatib , Ali McBride , Marion Slack , Sandipan Bhattacharjee , Brian Erstad , Kenneth Ramos & Ivo Abraham
Pages: 1266-1272
Published online: 08 Sep 2020
Abstract | Full Text | References | PDF (1029 KB) | Permissions聽

  • 190Views
  • 1CrossRef citations
  • Altmetric
Methods and Modelling
旺财体育
Dehydrated human amnion and chorion allograft versus standard of care alone in treatment of Wagner 1 diabetic foot ulcers: a trial-based health economics study
Marissa J. Carter
Pages: 1273-1283
Published online: 08 Aug 2020
Abstract | Full Text | References | PDF (1470 KB) | Permissions聽

  • 538Views
  • 0CrossRef citations
  • Altmetric
Health Technology
旺财体育
Cost-utility analysis of normothermic liver perfusion with the OrganOx metra compared to static cold storage in the United Kingdom
Mehdi Javanbakht , Atefeh Mashayekhi , Miranda Trevor , Michael Branagan-Harris & Jowan Atkinson
Pages: 1284-1292
Published online: 27 Aug 2020
Abstract | Full Text | References | PDF (1670 KB)聽

  • 45Views
  • 0CrossRef citations
  • Altmetric
Healthcare Systems
旺财体育
Cost-effectiveness and budget impact analysis of a patient visit support system for blindness reduction in Japanese patients with glaucoma
Masakazu Yamada , Tadashi Nakano , Hiroyuki Matsuda , Seok-Won Kim & Yasutaka Takagi
Pages: 1293-1301
Published online: 27 Aug 2020
Abstract | Full Text | References | PDF (1350 KB) | Permissions聽

  • 505Views
  • 0CrossRef citations
  • Altmetric
Gastroenterology
旺财体育
Cost-effectiveness and budget impact analysis of infliximab and its biosimilar in patients with refractory moderate-to-severe Crohn鈥檚 disease using real world evidence in Thailand
Pochamana Phisalprapa , Chayanis Kositamongkol , Julajak Limsrivilai , Satimai Aniwan , Phunchai Charatcharoenwitthaya , Pises Pisespongsa , Taya Kitiyakara , Suporn Treepongkaruna & Nathorn Chaiyakunapruk
Pages: 1302-1310
Published online: 13 Aug 2020
Abstract | Full Text | References | PDF (1903 KB) | Supplemental聽

  • 97Views
  • 0CrossRef citations
  • Altmetric
Diabetes
旺财体育
Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective
Johan Jendle , 脜sa Ericsson , Bertil Ekman , Stefan Sj枚berg , Jens Gundgaard , Jo茫o da Rocha Fernandes , Ann-Charlotte M氓rdby , Barnaby Hunt , Samuel J. P. Malkin & Maria Thunander
Pages: 1311-1320
Published online: 14 Sep 2020
Abstract | Full Text | References | PDF (1713 KB) | Supplemental | Permissions聽

  • 373Views
  • 0CrossRef citations
  • Altmetric
Oncology
旺财体育
Cost utility analysis of tisagenlecleucel vs salvage chemotherapy in the treatment of relapsed/refractory diffuse large B-cell lymphoma from Singapore鈥檚 healthcare system perspective
Boon Piang Cher , Kar Yee Gan , Mohamed Ismail Abdul Aziz , Liang Lin , William Ying Khee Hwang , Li Mei Poon & Kwong Ng
Pages: 1321-1329
Published online: 25 Aug 2020
Abstract | Full Text | References | PDF (1822 KB) | Supplemental聽

  • 118Views
  • 0CrossRef citations
  • Altmetric
旺财体育
Cost-effectiveness analysis of osimertinib for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small cell lung cancer in Singapore
Mohamed Ismail Abdul Aziz , Wayne Yong Xiang Foo , Chee Keong Toh , Wan-Teck Lim & Kwong Ng
Pages: 1330-1339
Published online: 21 Sep 2020
Abstract | Full Text | References | PDF (1425 KB)聽

  • 58Views
  • 0CrossRef citations
  • Altmetric
旺财体育
Cost-effectiveness analysis of the SP142 versus 22C3 PD-L1 assays in the treatment of atezolizumab plus nab-paclitaxel for patients with advanced triple negative breast cancer in the Brazilian private healthcare system
Rodrigo Shimabukuro Ho , Mariana Mioti Sebasti茫o , Jo茫o Paulo Venezian de Carvalho , Tom谩s Neves & Micha Nussbaum
Pages: 1340-1344
Published online: 26 Sep 2020
Abstract | Full Text | References | PDF (764 KB) | Supplemental | Permissions聽

  • 776Views
  • 0CrossRef citations
  • Altmetric
Health Financing
旺财体育
Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance 鈥� the perspective of private and public payers
Nirmish R. Shah , Menaka Bhor , Dominick Latremouille-Viau , Vikash Kumar Sharma , Gary A. Puckrein , Patrick Gagnon-Sanschagrin , Ankur Khare , Mukesh Kumar Singh , Elizabeth Serra , Mikha茂l Davidson , Liou Xu & Annie Guerin
Pages: 1345-1355
Published online: 09 Sep 2020
Abstract | Full Text | References | PDF (1750 KB) | Supplemental聽

  • 119Views
  • 0CrossRef citations
  • Altmetric
Neurology
旺财体育
Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database
Shonda A. Foster , Chi-Chang Chen , Yao Ding , Oksana Mason , Catherine B. McGuiness , Paula Morrow , Wenyu Ye , Rolin L. Wade , Timothy R. Smith & Shivang Joshi
Pages: 1356-1364
Published online: 12 Sep 2020
Abstract | Full Text | References | PDF (1307 KB) | Permissions聽

  • 450Views
  • 0CrossRef citations
  • Altmetric
Cardiovascular
旺财体育
Healthcare costs of NVAF patients treated with rivaroxaban and apixaban in the US
Dejan Milentijevic , Guillaume Germain , Fran莽ois Lalibert茅 , Brahim K. Bookhart , Sean D. MacKnight , Jenkin Tsang & Patrick Lefebvre
Pages: 1365-1374
Published online: 29 Sep 2020
Abstract | Full Text | References | PDF (926 KB) | Supplemental | Permissions聽

  • 543Views
  • 0CrossRef citations
  • Altmetric